MSH3 and cancer: Promoter hypermethylation and mutational silencing of HR and MMR genes, such as RB, BRCA1/2, PTEN, MLH1, MSH3, MSH6 have been identified in human cancer (Bhattacharya and Patel 2018; Hatziapostolou and Iliopoulos 2011).